13F Data
13F filer · CIK 1511901

Broadfin Capital, LLC

New York, NY · filing since Q2 2013 · last filing Feb 14, 2020
Reported value
$823.2M
$-2.4M vs prior
Positions
54
New / sold out
15 / 16
Added / reduced
12 / 19
Turnover
18.5%
buys $152.9M · sells $163.3M
Top-10 weight
55.1%

Biggest buys vs Q1 2017

ChangeSecurityShares changeChange %Est. trade value
NewIOVANCE BIOTHERAPEUTICS INC+2,276,359–+$16.7M
NewAERIE PHARMACEUTICALS INC+310,000–+$16.3M
NewALNYLAM PHARMACEUTICALS INC+181,200–+$14.5M
AddedLA JOLLA PHARMACEUTICAL CO+475,000+60.7%+$14.1M
NewGILEAD SCIENCES INCCALL+180,000–+$12.7M
AddedCORIUM INTL INC+1,649,605+59.2%+$12.3M
NewNOVADAQ TECHNOLOGIES INC+1,000,000–+$11.7M
AddedARATANA THERAPEUTICS INC+1,489,500+40.3%+$10.8M
NewLA JOLLA PHARMACEUTICAL COCALL+150,000–+$4.5M
NewNUVASIVE INC+55,900–+$4.3M
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2017

ChangeSecurityShares changeChange %Est. trade value
ReducedHORIZON PHARMA PLC-1,603,372-28.3%$-19.0M
Sold outLION BIOTECHNOLOGIES INC-2,509,059-100.0%$-18.7M
Sold outADVAXIS INC-1,519,259-100.0%$-12.4M
Sold outMEDICINES CO-215,077-100.0%$-10.5M
ReducedANTARES PHARMA INC-2,838,678-37.1%$-9.1M
Sold outDURECT CORP-8,506,229-100.0%$-8.9M
Sold outSEASPINE HLDGS CORP-1,099,807-100.0%$-8.6M
ReducedHERON THERAPEUTICS INC-529,044-10.7%$-7.3M
ReducedENDO INTL PLC-636,815-33.8%$-7.1M
Sold outBARD C R INC-27,300-100.0%$-6.8M
25 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $511.2MQ3 2013: $563.3MQ4 2013: $758.2MQ1 2014: $1.0BQ2 2014: $2.0BQ3 2014: $953.8MQ4 2014: $1.2BQ1 2015: $1.3BQ2 2015: $1.9BQ3 2015: $1.8BQ4 2015: $1.6BQ1 2016: $1.0BQ2 2016: $1.0BQ3 2016: $1.1BQ4 2016: $900.7MQ1 2017: $825.6MQ2 2017: $823.2MQ3 2017: $676.0MQ4 2017: $611.8MQ1 2018: $641.7MQ2 2018: $635.2MQ3 2018: $679.5MQ4 2018: $760.5MQ1 2019: $484.3MQ2 2019: $459.6MQ3 2019: $540.9MQ4 2019: $746.8M
Q2 2013Q4 2019

Holdings · Q2 2017

#SecuritySharesValueWeight
1SPDR SERIES TRUSTPUTS&P BIOTECH1,000,000$77.2M9.38%
2HERON THERAPEUTICS INCCOM4,418,359$61.2M7.43%
3RETROPHIN INCCOM2,862,178$55.5M6.74%
4HORIZON PHARMA PLCSHS4,060,847$48.2M5.86%
5AVADEL PHARMACEUTICALS PLCSPONSORED ADR4,133,464$45.6M5.54%
6ARATANA THERAPEUTICS INCCOM5,184,942$37.5M4.55%
7LA JOLLA PHARMACEUTICAL COCOM PAR $.0001 21,257,887$37.4M4.55%
8CORIUM INTL INCCOM4,436,726$33.1M4.02%
9IGNYTA INCCOM2,941,247$30.4M3.70%
10ANGIODYNAMICS INCCOM1,683,252$27.3M3.31%
44 more rows. Subscribe for $29/month to see every row, download the data and use the API.